Anbio Biotechnology
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $4.2M |
| FY2022 | — | — | $7.1M |
| FY2023 | $993.1K | $15.8M | $9.7M |
| FY2024 | $1.7M | $18.9M | $11.8M |
| FY2025 | $87.8K | $30.2M | $7.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | — | — | $4.2M |
| FY2022 | — | — | $7.1M |
| FY2023 | $993.1K | $15.8M | $9.7M |
| FY2024 | $1.7M | $18.9M | $11.8M |
| FY2025 | $87.8K | $30.2M | $7.8M |